What Have You Missed?
With over 400 radiopharmaceuticals in active development and expanding rapidly into new disease indications, the field has untapped potential that should not be held back.
That's why the Targeted Radiopharmaceuticals Summit Europe was back in 2025 with its most comprehensive programme yet – featuring a brand-new dedicated track spotlighting the latest industry breakthroughs and tackling today’s biggest challenges head-on.
Across three days, you dove into a focused agenda built around the real issues shaping the future of TRPs – from securing reliable isotope supply and designing smarter clinical studies, to advancing dosimetry, refining molecular design, and accelerating regulatory approvals and commercialisation.
You Have Left With Actionable Takeaways
Whether you were building an early-stage pipeline or preparing for late-stage scale-up, this was your opportunity to connect with others facing the same challenges, and to move your programme forward with greater speed and confidence.
Turn early clinical signals into strong preclinical and first-in-human strategies
Fine-tune trial design, dosimetry, and dosing for new and emerging targets
Navigate isotope access, manufacturing challenges, and regulatory complexity
Tackle cross-border supply and logistical hurdles unique to Europe
Attending Companies Included
Explore the Agenda
Explore the latest industry breakthroughs and get exclusive insights into radiopharmaceutical innovations with our expanded three-track agenda, covering discovery, preclinical research, translational science, clinical progress, CMC, and supply chain strategies.
Partner With Us
Align yourself with other leading solution providers to ensure your brand remains central to key biopharma deals and decision-making.
Join Biopharma Experts
Join the most important conversations with like-minded professionals across all stages of drug development, and build critical connections during dedicated networking sessions designed to foster collaboration and harmonisation throughout the entire development journey.